|
ARCA Biopharma's Special Dividend Amid Merger Talks: What Investors Need to Know
On August 26, 2024, ARCA biopharma, Inc. (NASDAQ: ABIO) released a press statement announcing a special dividend of $1.613 per share of common stock, which is to be distributed on August 28, 2024. This dividend is a notable component of the company's forthcoming merger with Oruka Therapeutics, Inc. The announcement follows the declaration made by ARCA's Board of Directors on August 16, 2024, and serves as a key financial event in the timeline of the merger outlined in the Agreement and Plan of Merger and Reorganization drawn up on April 3, 2024.
Key Facts from the Update:
1. Dividend Amount: The final special cash dividend has been set at $1.613 per share.
2. Payment Date: The dividend will be payable to stockholders of record as of August 26, 2024, with actual distribution occurring on August 28, 2024.
3. Merger Context: The special dividend is tied to ARCA’s merger with Oruka Therapeutics, indicating its strategic role within the broader business transaction.
4. Financial Trigger: The dividend amount was determined by an approximation of ARCA's net cash position exceeding $5,000,000 prior to the merger's closing.
5. Stock Performance: Despite recent fluctuations, ARCA's stock demonstrated resilience, recording a solid gain of 7.66% over the last five days, although it remains down 22.37% in Q3 2024 and trading 24.5% above its 52-week average.
|
